Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen
- 1 February 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (2) , 447-451
- https://doi.org/10.1016/s0002-9378(94)70209-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer—Preliminary reportGynecologic Oncology, 1991
- Four case reports presenting new acquisitions on the association between breast and endometrial carcinomaGynecologic Oncology, 1990
- Hysteroscopic follow-up during Tamoxifen treatmentEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- Tamoxifen for breast cancer: Associated endometrial cancerCancer, 1990
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUMThe Lancet, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- PELVIC IRRADIATION AND TAMOXIFEN AS RISK FACTORS FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetateGynecologic Oncology, 1988
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984